Volume Alert - OREX 5.80 Orexigen Therapeutics $OREX Hit a

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 2:53 PM

Volume Alert - OREX 5.80 Orexigen Therapeutics $OREX Hit a high today of 6.02 Closing the day 10:30 at 5.80 -0.06 -1.02% With a day low of 5.77 and a total volume of 740,142.

OREX Recent Posts: http://investorshangout.com/Orexigen-Therapeu...REX-55007/

OREX Orexigen Therapeutics Recent Headline News

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind
at The Street - Fri Nov 14, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care.
OREX: 5.50 (-0.36), AMRN: 0.94 (-0.01), ICPT: 160.22 (+1.36), SPPI: 7.20 (-0.05), MNKD: 6.11 (-0.07)

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.28 (-0.24), IMDZ: 35.40 (-0.57), OLED: 27.50 (+0.30), FUEL: 18.50 (-0.70), CZR: 16.83 (+0.32), NTIC: 20.00 (-0.75), RESN: 7.12 (-0.07), OREX: 5.50 (-0.36), VBFC: 20.50 (-0.55), FLML: 13.14 (-0.25), ACHN: 13.88 (+0.39), RDI: 11.99 (+0.01), AMOT: 19.15 (-0.12), SUSQ: 13.09 (+0.03), RDIB: 12.00 (-0.04)

Most active Nasdaq-traded stocks
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
BAXS: 0.03 (-0.03), FB: 74.86 (+0.61), CMCSK: 53.81 (-0.22), INTC: 33.92 (+0.24), OREX: 5.50 (-0.36), GILD: 101.74 (-2.46), ZNGA: 2.74 (+0.01), GRPN: 7.82 (+0.05), MSFT: 49.47 (-0.14), CMCSA: 53.98 (-0.32), SUSQ: 13.09 (+0.03), AAPL: 113.83 (+1.01), CSCO: 26.26 (+0.58)

5 Momentum Stocks Currently on the Move with More Potential Upside
at The Street - Thu Nov 13, 11:34AM CST
Achillion, Groupon, Orexigen, Rackspace and TG Therapeutics have had strong recent moves and are showing no sign of slowing.
OREX: 5.50 (-0.36), RAX: 43.69 (+0.36), ACHN: 13.88 (+0.39), TGTX: 13.92 (+0.05), GRPN: 7.82 (+0.05)

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
Lance Brofman - at Seeking Alpha - Thu Nov 13, 8:52AM CST

OREX: 5.50 (-0.36), HLF: 38.50 (+0.65), NVO: 44.06 (+0.04), VVUS: 3.25 (-0.01), AMGN: 156.86 (-3.99), GSK: 45.73 (+0.07), ARNA: 4.56 (-0.05)

Critical Alerts For Caesars Entertainment, Orexigen Therapeutics, Amazon.com, Toyota Motor and Amgen Released By InvestorsObserver
PR Newswire - Thu Nov 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for CZR, OREX, AMZN, TM and AMGN.
AMZN: 329.05 (+12.57), OREX: 5.50 (-0.36), AMGN: 156.86 (-3.99), TM: 119.62 (-0.20), CZR: 16.83 (+0.32)

Orexigen Therapeutics' (OREX) CEO Michael Narachi Presents at Credit Suisse Healthcare Conference (Transcript)
SA Transcripts - at Seeking Alpha - Wed Nov 12, 2:28PM CST

OREX: 5.50 (-0.36)

Orexigen Therapeutics Continues To Rally
at The Street - Wed Nov 12, 12:02PM CST
Caesars Entertainment Corp (NASDAQ:CZR), Orexigen Therapeutics, Inc. (NASDAQ:OREX) and Fossil Group Inc (NASDAQ:FOSL) reached midday with major gains. Taking tumbles midday are Altisource Portfolio...
OREX: 5.50 (-0.36), FOSL: 108.02 (-1.79), ASPS: 51.63 (-3.37), CZR: 16.83 (+0.32)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:45AM CST

LTBR: 1.97 (-0.08), ASPS: 51.63 (-3.37), AETI: 5.89 (+0.13), PLUG: 3.74 (-0.32), MOC: 1.88 (-0.07), CRDS: 2.65 (+0.08), STKL: 12.29 (+0.02), BIOC: 3.34 (-0.12), CZR: 16.83 (+0.32), MATX: 34.36 (+0.12), NTIC: 20.00 (-0.75), SDPI: 5.28 (+0.03), RESN: 7.12 (-0.07), OREX: 5.50 (-0.36), FLL: 1.21 (unch), VGGL: 2.72 (-0.20), CGG: 9.21 (+0.52), SUSQ: 13.09 (+0.03), SINO: 1.81 (unch), ELMD: 2.03 (+0.03)

Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST

OREX: 5.50 (-0.36), VVUS: 3.25 (-0.01), ARNA: 4.56 (-0.05)

Uptrend Call Working As Orexigen Therapeutics Stock Rises 23.6% (OREX)
Comtex SmarTrend(R) - Tue Nov 11, 11:04AM CST
SmarTrend identified an Uptrend for Orexigen Therapeutics (NASDAQ:OREX) on October 17th, 2014 at $4.16. In approximately 4 weeks, Orexigen Therapeutics has returned 23.56% as of today's recent price of $5.14.
OREX: 5.50 (-0.36)

Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 5.50 (-0.36), VVUS: 3.25 (-0.01), AMAG: 33.77 (-0.47)

Orexigen (OREX) Worth Watching: Stock Soars 33.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:25AM CST
Orexigen (OREX) was a big mover last session, with shares surging over 33% on the day.
BIIB: 306.04 (-11.94), OREX: 5.50 (-0.36), AMAG: 33.77 (-0.47), AFFX: 9.69 (unch)

Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 5.50 (-0.36), VVUS: 3.25 (-0.01), ARNA: 4.56 (-0.05)

Look for Shares of Orexigen Therapeutics to Potentially Pullback after Yesterday's 33.25% Rise
Comtex SmarTrend(R) - Mon Nov 10, 5:24PM CST
Orexigen Therapeutics (NASDAQ:OREX) traded in a range yesterday that spanned from a low of $4.04 to a high of $5.33. Yesterday, the shares gained 33.2%, which took the trading range above the 3-day high of $4.08 on volume of 15.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OREX: 5.50 (-0.36)

Market News: Apple,FireEye, Orexigen Therapeutics
at The Street - Mon Nov 10, 4:17PM CST
Oppenheimer market strategist, John Stoltzfus estimated that the S&P 500 could reach as 2,080 pointsThe stock markets in the United States ended the trading session higher as investors speculated that...
OREX: 5.50 (-0.36), FEYE: 33.76 (+0.42), AAPL: 113.82 (+1.00)

Dean Foods and Toll Brothers are big market movers
AP - Mon Nov 10, 3:48PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
DVAX: 14.62 (-0.98), OREX: 5.50 (-0.36), RYN: 26.01 (-0.12), MRK: 58.92 (-0.62), CMCSK: 53.81 (-0.22), DF: 16.68 (+0.01), TOL: 33.78 (+0.05), CMCSA: 53.98 (-0.32)

Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
at The Street - Mon Nov 10, 1:53PM CST
Orexigen Therapeutics (OREX) stock is up after the company said the European Union review of its drug is progressing, as it reported better than expected third quarter earnings this morning.
OREX: 5.50 (-0.36)

Orexigen Therapeutics (OREXQ) Stock Research Links

OREXQ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyperscale Recalibrates: AI Boom or Risky Bet?

Is Hyperscale Making the Right Move? Hyperscale Data, Inc. waved goodbye to the Bitcoin mining days to clear the stage for artificial intelligence (AI). But is this strategic leap off the blockchain and into AI territory as golden as promised? Whisper around the street is it could turn into a $3 billion windfall. But let's chew through the details before toasting...

ADA Audit Reveals Gaps in Event Management at 2026 Session

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

Corner Bakery Cafe Unveils Fall Treat Lineup

Get Ready for a Fall Feast at Corner Bakery Cafe Pumpkin spice season is here, whether you're thrilled or grumbling about it. Corner Bakery Cafe is throwing its hat in the seasonal ring, bringing back its crowd-pleaser Pumpkin Latte—available hot, iced, or as a cold brew. They're also rolling out a lineup full of tempting treats aimed to capture those autumn cravings....

3D Cloud Expands with Enhanced Visual CPQ Capabilities

Changing the Game in Complex Product Configuration It's a new dawn in how customers tinker with custom products. Talk about blasting through the old convolutions of configuration. 3D Cloud's fresh offering makes product configuration a breeze, very much like choosing ingredients for a custom sandwich and seeing it come to life. Frankly, the introduction of 3D Visual CPQ...

BKF's Strategic Move: Andrew Esposito Steps In Don't walk past a headline like this without feeling the pulse of BKF's ambitious strides in the AEC industry. BKF, a heavyweight in the architecture, engineering, and construction sector, has tapped Andrew Esposito as its new Chief Financial Officer. Based out in sunny Oakland, California, they're looking to crank up their...

American Tungsten's Bold Play in Nevada is Noteworthy

American Tungsten's Shifting Focus Today we're chewing over some intriguing moves from American Tungsten & Antimony, Ltd. (ASX: AT4; OTCQX: ATALF). These cats are eyeing a chunk of the strategic metals market. They've engaged Metso Finland Oy to whip up a Scoping Study for an ammonium paratungstate (APT) production circuit at their Del Sol Refinery in Nevada. Why Tungsten...

Trua Embarks on New Senior Support Journey in GA

A New Chapter for Senior Care in South Fulton Here's a story that's probably tugging a few heartstrings: Trua Senior Living Locators has kicked off operations in South Fulton. This isn't just another business launch; it's a tale deeply rooted in personal experience. The man at the helm, Fred Giahi, knows firsthand the trials and tribulations families face when dealing...

Charter CFO to Speak at Citi TMT Conference 2026

Charting Charter's Future Moves at the Citi TMT Conference There's something electric about a company like Charter Communications showing up at a big-deal event like the Citi Global TMT Conference. It's not just another day in the office when Jessica Fischer, the Chief Financial Officer, steps up to the mic on September 10, 2026. Investors better have their ears perked...

BD&J Shines in Elite 2026 Legal Ranking for California

A Rare Nod from Chambers and Partners Now and then, the legal spotlight lands in places you don't quite expect. This time, it’s BD&J—a stalwart of the personal injury field—grabbing the limelight right from under the noses of California's Big Law giants. This firm has been pegged as a top contender in the 2026 Chambers and Partners Spotlight Guide. And let me tell...

Nozomi Networks: Leading OT Security in 2026

One Year of Massive Wins for Nozomi Networks Here's a wild trajectory: Nozomi Networks has been firing on all cylinders in 2026, capturing attention not just from analysts but also from anyone with a stake in the security game. The company’s impressive run was highlighted most recently when they were crowned a Leader in The Forrester Wave: Operational Technology...